Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan A Lee

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Cell Chemical Biology|February 16, 2021
Nuisance compounds in cellular assaysJayme L Dahlin, Douglas S Auld, Ina Rothenaigner, et al.
Plos One|July 16, 2015
Novel Phenotypic Outcomes Identified for a Public Collection of Approved Drugs from a Publicly Accessible Panel of AssaysJonathan A Lee, Paul Shinn, Susan Jaken, et al.
Journal of Medicinal Chemistry|January 23, 2004
Synthesis and structure-activity relationships of novel arylpiperazines as potent and selective agonists of the melanocortin subtype-4 receptorTimothy I Richardson, Paul L Ornstein, Karin Briner, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Cell Chemical Biology|February 16, 2021
Nuisance compounds in cellular assaysJayme L Dahlin, Douglas S Auld, Ina Rothenaigner, et al.
Plos One|July 16, 2015
Novel Phenotypic Outcomes Identified for a Public Collection of Approved Drugs from a Publicly Accessible Panel of AssaysJonathan A Lee, Paul Shinn, Susan Jaken, et al.
Journal of Medicinal Chemistry|January 23, 2004
Synthesis and structure-activity relationships of novel arylpiperazines as potent and selective agonists of the melanocortin subtype-4 receptorTimothy I Richardson, Paul L Ornstein, Karin Briner, et al.
Pageof 2